BMJ Sexual & Reproductive Health最新文献

筛选
英文 中文
Free emergency contraception in pharmacies: a snapshot of local impact from Kirklees. 药房免费紧急避孕:Kirklees对当地影响的快照。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-03-30 DOI: 10.1136/bmjsrh-2025-203138
Kate Hamilton, Rebecca Gunn, Rebecca Strauss
{"title":"Free emergency contraception in pharmacies: a snapshot of local impact from Kirklees.","authors":"Kate Hamilton, Rebecca Gunn, Rebecca Strauss","doi":"10.1136/bmjsrh-2025-203138","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203138","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147580548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abortion exceptionalism in research governance: why naming the problem matters. 研究治理中的堕胎例外论:为什么指出问题很重要。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-03-30 DOI: 10.1136/bmjsrh-2026-203263
Nicola Boydell, John Joseph Reynolds-Wright, Marie Larsson, Jacqueline Quinn, Sharon Cameron, Jeni Harden
{"title":"Abortion exceptionalism in research governance: why naming the problem matters.","authors":"Nicola Boydell, John Joseph Reynolds-Wright, Marie Larsson, Jacqueline Quinn, Sharon Cameron, Jeni Harden","doi":"10.1136/bmjsrh-2026-203263","DOIUrl":"https://doi.org/10.1136/bmjsrh-2026-203263","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147580575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights from the literature. 文献中的亮点。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-03-11 DOI: 10.1136/bmjsrh-2025-203054
{"title":"Highlights from the literature.","authors":"","doi":"10.1136/bmjsrh-2025-203054","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203054","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147430993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symptom profiles in the late reproductive stage, earlier premenopause and early perimenopause in the absence of vasomotor symptoms: a cross-sectional study. 在没有血管舒缩症状的生殖晚期、绝经前早期和围绝经期早期的症状概况:一项横断面研究。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-03-11 DOI: 10.1136/bmjsrh-2025-203075
Santina Bresolin, Rakibul M Islam, Molly Bond, Susan R Davis
{"title":"Symptom profiles in the late reproductive stage, earlier premenopause and early perimenopause in the absence of vasomotor symptoms: a cross-sectional study.","authors":"Santina Bresolin, Rakibul M Islam, Molly Bond, Susan R Davis","doi":"10.1136/bmjsrh-2025-203075","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203075","url":null,"abstract":"<p><strong>Background: </strong>Perimenopause is formally diagnosed by menstrual bleeding patterns. This study investigated whether symptoms in the late reproductive stage (LRS), characterised by changed menstrual flow, differ from earlier premenopause or from perimenopause in the absence of vasomotor symptoms (VMS).</p><p><strong>Methods: </strong>The Australian Women's Midlife Years Study (2023-2024) was a nationally representative cross-sectional study of 8096 women aged 40-69 years, who completed the Menopause-specific Quality of Life Questionnaire (MENQOL). The prevalence of moderate-to-severe symptoms in participants without VMS was analysed using generalised linear models with Gamma log link and modified Poisson regression with robust variance, respectively.</p><p><strong>Results: </strong>The analysis included 1039 respondents without VMS, of which 63.5% (n=660) had regular menses with no change in menstrual flow, 20.1% (n=209) had regular menses with changed flow, and 16.4% (n=170) were perimenopausal (cycle variation at least 7 days). Premenopausal participants with unchanged flow were less likely to report poor memory (adjusted prevalence ratio (aPR) 0.60, 95% CI 0.43 to 0.83, p=0.043), 'accomplishing less than used to' (aPR 0.65, 95% CI 0.50 to 0.85, p=0.014), 'feeling tired or worn out' (aPR 0.78, 95% CI 0.68 to 0.90, p=0.009) and bloating (aPR 0.63, 95% CI 0.49 to 0.80, p=0.004) compared with LRS participants. The other 18 individual MENQOL symptoms did not differ between premenopausal LRS and early perimenopause.</p><p><strong>Conclusions: </strong>Premenopausal women with regular menstrual cycles reporting changed menstrual flow but no VMS differ little from those without VMS and no change in menstrual flow. This indicates that change in flow alone is not a clear indicator of commencement of the menopause transition.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147431024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social media narratives regarding Opill®: public discourse analysis around the first over-the-counter birth control pill. 关于Opill®的社交媒体叙述:围绕第一种非处方避孕药的公共话语分析。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-02-20 DOI: 10.1136/bmjsrh-2025-203093
Mikaela Koch, Song Hyun Kim, Pavithra Sundaravaradan, Hayoung E Ahn, Milan V Carter, Serinee H Tran, Maral Demirjian, Lorna Kwan, Aparna Sridhar
{"title":"Social media narratives regarding Opill®: public discourse analysis around the first over-the-counter birth control pill.","authors":"Mikaela Koch, Song Hyun Kim, Pavithra Sundaravaradan, Hayoung E Ahn, Milan V Carter, Serinee H Tran, Maral Demirjian, Lorna Kwan, Aparna Sridhar","doi":"10.1136/bmjsrh-2025-203093","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203093","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146257442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preconception care for men: a scoping review of knowledge, behaviours and interventions. 男性孕前护理:知识、行为和干预措施的范围审查。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-01-20 DOI: 10.1136/bmjsrh-2025-202975
Gabriella Citra, Yuyu Sumiya, Gessica Augustin, Daichi Suzuki, Shuxian Liu, Maria Lohan, Hitomi Suzuki, Naoko Arata, Asako Mito, Erika Ota
{"title":"Preconception care for men: a scoping review of knowledge, behaviours and interventions.","authors":"Gabriella Citra, Yuyu Sumiya, Gessica Augustin, Daichi Suzuki, Shuxian Liu, Maria Lohan, Hitomi Suzuki, Naoko Arata, Asako Mito, Erika Ota","doi":"10.1136/bmjsrh-2025-202975","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-202975","url":null,"abstract":"<p><strong>Aim: </strong>This scoping review mapped quantitative evidence on men's preconception care (PCC) focusing on: (1) knowledge, (2) behaviours and attitudes, (3) reproductive intentions and (4) outcomes of educational or counselling interventions. The review also sought to identify evidence gaps and inform future policies and practices to enhance male engagement in reproductive health.</p><p><strong>Methods: </strong>Quantitative studies involving men aged ≥18 years from high- and upper-middle-income countries were included. Studies focusing on couples, non-English-language publications, qualitative research, reviews and commentaries were excluded. Quantitative designs were prioritised to map measurable determinants and outcomes of engagement in PCC. Searches were conducted across seven databases in September 2025, following the PRISMA-ScR framework. No critical appraisal was performed, consistent with scoping review methodology.</p><p><strong>Results: </strong>Fourteen studies (n=18 733 men) were included, most of which were observational. Findings indicated low fertility awareness, inconsistent engagement in preconception behaviours, and minimal use of supplements or healthcare services. Differences were noted by age, education and fatherhood status. One intervention improved knowledge but did not address systemic barriers.</p><p><strong>Conclusions: </strong>Men remain underrepresented in PCC. Gender-transformative, system-level reforms integrating men into primary care, health education and public messaging are needed. Future research should test context-specific, equity-oriented interventions to promote inclusive PCC for all.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146009016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of pregnancy intentions in emergency department patients with pregnancy of unknown location. 急诊不明部位妊娠患者妊娠意向评估。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-01-16 DOI: 10.1136/bmjsrh-2025-203152
Alexis A Doyle, Isabel Beshar, Andrea Henkel, Carl Preiksaitis, Corrine A Nief, Lisandra Veliz Dominguez, Elisa Padron, Serena M Liu, Jade M Shorter
{"title":"Assessment of pregnancy intentions in emergency department patients with pregnancy of unknown location.","authors":"Alexis A Doyle, Isabel Beshar, Andrea Henkel, Carl Preiksaitis, Corrine A Nief, Lisandra Veliz Dominguez, Elisa Padron, Serena M Liu, Jade M Shorter","doi":"10.1136/bmjsrh-2025-203152","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203152","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988271","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service. 在人工流产服务中实施β-人绒毛膜促性腺激素的即时检测。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-01-16 DOI: 10.1136/bmjsrh-2025-203072
Jacqueline Quinn, John Joseph Reynolds-Wright, Karen McCabe, Seonaid Boyle, Gordon Marr, Sharon T Cameron
{"title":"Implementing a point-of-care test for β-human chorionic gonadotropin testing within an abortion service.","authors":"Jacqueline Quinn, John Joseph Reynolds-Wright, Karen McCabe, Seonaid Boyle, Gordon Marr, Sharon T Cameron","doi":"10.1136/bmjsrh-2025-203072","DOIUrl":"https://doi.org/10.1136/bmjsrh-2025-203072","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145988298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sexual and reproductive health clinical consultations: Contraception and HIV antiretroviral therapy. 性健康和生殖健康临床咨询:避孕和艾滋病毒抗逆转录病毒治疗。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-01-15 DOI: 10.1136/bmjsrh-2024-202602
Sian Pearson, Nadi Gupta
{"title":"Sexual and reproductive health clinical consultations: Contraception and HIV antiretroviral therapy.","authors":"Sian Pearson, Nadi Gupta","doi":"10.1136/bmjsrh-2024-202602","DOIUrl":"10.1136/bmjsrh-2024-202602","url":null,"abstract":"","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"75-77"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pain management for medical abortion beyond 12 weeks of gestation: a cross-sectional study in Sweden. 妊娠12周以上药物流产的疼痛管理:瑞典的一项横断面研究。
IF 2.8 3区 医学
BMJ Sexual & Reproductive Health Pub Date : 2026-01-15 DOI: 10.1136/bmjsrh-2024-202691
Johanna Rydelius, Helena Kopp Kallner, Ove Karlsson, Helena Hognert, Kristina Gemzell-Danielsson
{"title":"Pain management for medical abortion beyond 12 weeks of gestation: a cross-sectional study in Sweden.","authors":"Johanna Rydelius, Helena Kopp Kallner, Ove Karlsson, Helena Hognert, Kristina Gemzell-Danielsson","doi":"10.1136/bmjsrh-2024-202691","DOIUrl":"10.1136/bmjsrh-2024-202691","url":null,"abstract":"<p><strong>Background: </strong>Medical abortion beyond 12 weeks' gestation increases experienced pain. The effectiveness of pain management protocols remains to be evaluated.</p><p><strong>Methods: </strong>This was a secondary analysis of a randomised controlled trial, conducted in six Swedish hospitals from 2019 to 2022, investigating home administration of the first misoprostol dose. Paracetamol 1000 mg and a non-steroidal anti-inflammatory drug (NSAID) were provided with the first misoprostol dose and subsequent breakthrough pain medication as required. We recruited persons >18 years of age, with a viable singleton pregnancy between 12 weeks+1 day and 21 weeks+6 days of gestation. We collected data on patient-reported pain using a visual analogue scale (VAS, 0-100 mm) at fetal expulsion and maximum pain assessed retrospectively prior to discharge. We collected data on the use of breakthrough pain medication, satisfaction scores with pain relief, and VAS scores before/after administration of breakthrough analgesia.</p><p><strong>Results: </strong>We included 425 individuals. The participants reported a mean VAS of 39.1 (SD 34.4) at expulsion and 65.4 (SD 28.6) as maximum pain (assessed after abortion before discharge) and 352/425 (82.8%) received breakthrough pain medication, with 266/425 (62.6%) receiving an oral opioid, 163/425 (38.4%) a paracervical block (PCB) and 86/425 (20.2%) a parenteral opioid. A total of 357/392 (91.1%) participants were satisfied with the pain relief. Administration of a PCB alone or following an opioid resulted in the largest decrease in VAS.</p><p><strong>Conclusions: </strong>Many participants reported high VAS scores but most of them were satisfied with their analgesic treatment. A PCB was associated with the highest effectiveness in alleviating pain.</p>","PeriodicalId":9219,"journal":{"name":"BMJ Sexual & Reproductive Health","volume":" ","pages":"19-25"},"PeriodicalIF":2.8,"publicationDate":"2026-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144820641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书